Overexpression of SIRT6 attenuates the tumorigenicity of hepatocellular carcinoma cells

被引：17
作者：
Wang, Yadong [1 ,2 ]
Pan, Teng [3 ]
Wang, Haiyu [1 ]
Li, Li [1 ]
Li, Jiangmin [1 ]
Zhang, Ding [1 ]
Yang, Haiyan [3 ]
机构：
[1] Henan Ctr Dis Control & Prevent, Dept Toxicol, Zhengzhou 450016, Henan, Peoples R China
[2] Xinxiang Med Univ, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Xinxiang 453003, Peoples R China
[3] Zhengzhou Univ, Sch Publ Hlth, Dept Epidemiol, Zhengzhou 450001, Henan, Peoples R China
来源：
ONCOTARGET | 2017年 / 8卷 / 44期
基金：
中国国家自然科学基金;
关键词：
SIRT6; HCC cell; tumorigenicity; cell cycle; HISTONE DEACETYLASE SIRT6; DNA-REPAIR; RAF KINASE; IN-VITRO; PROTEIN; CANCER; EXPRESSION; PATHWAY; GROWTH; CARCINOGENESIS;
D O I：
10.18632/oncotarget.19297
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Objective: This study aimed to explore the effects of overexpression of sirtuin 6 (SIRT6) on the tumorigenicity of hepatocellular carcinoma (HCC) cells. Methods: Stable SIRT6-overexpressed HCC cell lines were established by transfecting SIRT6 plasmid. Soft agar assay and tumor xenograft assay in nude mice were applied. Flow cytometry was employed to detect cell cycle distribution. Western blotting analysis was used to detect the expression of proteins. Results: Overexpression of SIRT6 attenuated HepG2 and HCCLM3 cells proliferation, colony formation in vitro and tumor formation in nude mice, and resulted in the G1 phase cell cycle arrest. Overexpression of SIRT6 reduced the expression of cyclin D1 and p-ERK proteins in both HepG2 and HCCLM3 cells. Conclusion: Overexpression of SIRT6 attenuates the tumorigenicity of HCC cells.
引用
收藏
页码：76223 / 76230
页数：8
相关论文
共 31 条
  • [1] Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway
    Bai, Lihong
    Lin, Gengpeng
    Sun, Longhua
    Liu, Yangli
    Huang, Xinyan
    Cao, Chuangjie
    Guo, Yubiao
    Xie, Canmao
    [J]. ONCOTARGET, 2016, 7 (26) : 40377 - 40386
  • [2] Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation
    Cai, Chun-Miao
    Xiao, Xu
    Wu, Bing-Hao
    Wei, Bao-Feng
    Han, Ze-Guang
    [J]. ONCOTARGET, 2016, 7 (44) : 71466 - 71476
  • [3] Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression
    Duan, Yujie
    Tian, Ling
    Gao, Qingzhu
    Liang, Li
    Zhang, Wenlu
    Yang, Yi
    Zheng, Yaqiu
    Pan, E.
    Li, Shengwei
    Tang, Ni
    [J]. ONCOTARGET, 2016, 7 (29) : 45863 - 45875
  • [4] Sirtuin 6 promotes transforming growth factor-1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence
    Feng, Xin-Xia
    Luo, Jing
    Liu, Mei
    Yan, Wei
    Zhou, Zhen-Zhen
    Xia, Yu-Jia
    Tu, Wei
    Li, Pei-Yuan
    Feng, Zuo-Hua
    Tian, De-An
    [J]. CANCER SCIENCE, 2015, 106 (05) : 559 - 566
  • [5] IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells
    Fernando, Romaine I.
    Castillo, Marianne D.
    Litzinger, Mary
    Hamilton, Duane H.
    Palena, Claudia
    [J]. CANCER RESEARCH, 2011, 71 (15) : 5296 - 5306
  • [6] Putative tumor suppression function of SIRT6 in endometrial cancer
    Fukuda, Tomohiko
    Wada-Hiraike, Osamu
    Oda, Katsutoshi
    Tanikawa, Michihiro
    Makii, Chinami
    Inaba, Kanako
    Miyasaka, Aid
    Miyamoto, Yuichiro
    Yano, Tetsu
    Maeda, Daichi
    Sasaki, Takeshi
    Kawana, Kei
    Fukayama, Masashi
    Osuga, Yutaka
    Fujii, Tomoyuki
    [J]. FEBS LETTERS, 2015, 589 (17) : 2274 - 2281
  • [7] RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo
    Gailhouste, Luc
    Ezan, Frederic
    Bessard, Anne
    Fremin, Christophe
    Rageul, Julie
    Langouet, Sophie
    Baffet, Georges
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (06) : 1367 - 1377
  • [8] SIRT6, a protein with many faces
    Gertler, Asaf A.
    Cohen, Haim Y.
    [J]. BIOGERONTOLOGY, 2013, 14 (06) : 629 - 639
  • [9] Role of Raf kinase in cancer: Therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway
    Gollob, Jared A.
    Wilhelm, Scott
    Carter, Chris
    Kelley, Susan L.
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (04) : 392 - 406
  • [10] Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8
1234